Suche senden
Hochladen
Poster Aacr 2010 Pettersson 2
•
Als PPT, PDF herunterladen
•
1 gefällt mir
•
439 views
F
FilippaP
Folgen
Poster AACR 2010
Weniger lesen
Mehr lesen
Melden
Teilen
Melden
Teilen
1 von 1
Jetzt herunterladen
Empfohlen
Clinical Surgery Research Communications
Artesunate improves drug resistance of lung carcinomas via regulation of mi r...
Artesunate improves drug resistance of lung carcinomas via regulation of mi r...
Clinical Surgery Research Communications
Clinical Surgery Research Communications
Resveratrol induces apoptosis, autophagy and endoplasmic reticulum stress in ...
Resveratrol induces apoptosis, autophagy and endoplasmic reticulum stress in ...
Clinical Surgery Research Communications
Clinical Surgery Research Communications
Mi r 449b inhibits the migration and invasion of colorectal cancer cells thro...
Mi r 449b inhibits the migration and invasion of colorectal cancer cells thro...
Clinical Surgery Research Communications
RoswellResearchPoster2015-ver2smaller-1
RoswellResearchPoster2015-ver2smaller-1
Korry Wirth
Poster AACR special meeting: Protein translation and cancer February 2010
Poster Aacr San Diego2010
Poster Aacr San Diego2010
FilippaP
Clinical Surgery Research Communications
Lnc rna neat1 is involved in temozolomide resistance by regulating mgmt in gl...
Lnc rna neat1 is involved in temozolomide resistance by regulating mgmt in gl...
Clinical Surgery Research Communications
MicroRNA Profiling of Hepatocellular Carcinomas in B6C3F1 Mice Treated with Ginkgo biloba Extract by Gavage for 2 Years
MicroRNA Profiling of Hepatocellular Carcinomas in B6C3F1 Mice Treated with G...
MicroRNA Profiling of Hepatocellular Carcinomas in B6C3F1 Mice Treated with G...
EPL, Inc.
Clinical Surgery Research Communications
A review of micro rn as related to the occurrence, diagnosis, and prognosis o...
A review of micro rn as related to the occurrence, diagnosis, and prognosis o...
Clinical Surgery Research Communications
Empfohlen
Clinical Surgery Research Communications
Artesunate improves drug resistance of lung carcinomas via regulation of mi r...
Artesunate improves drug resistance of lung carcinomas via regulation of mi r...
Clinical Surgery Research Communications
Clinical Surgery Research Communications
Resveratrol induces apoptosis, autophagy and endoplasmic reticulum stress in ...
Resveratrol induces apoptosis, autophagy and endoplasmic reticulum stress in ...
Clinical Surgery Research Communications
Clinical Surgery Research Communications
Mi r 449b inhibits the migration and invasion of colorectal cancer cells thro...
Mi r 449b inhibits the migration and invasion of colorectal cancer cells thro...
Clinical Surgery Research Communications
RoswellResearchPoster2015-ver2smaller-1
RoswellResearchPoster2015-ver2smaller-1
Korry Wirth
Poster AACR special meeting: Protein translation and cancer February 2010
Poster Aacr San Diego2010
Poster Aacr San Diego2010
FilippaP
Clinical Surgery Research Communications
Lnc rna neat1 is involved in temozolomide resistance by regulating mgmt in gl...
Lnc rna neat1 is involved in temozolomide resistance by regulating mgmt in gl...
Clinical Surgery Research Communications
MicroRNA Profiling of Hepatocellular Carcinomas in B6C3F1 Mice Treated with Ginkgo biloba Extract by Gavage for 2 Years
MicroRNA Profiling of Hepatocellular Carcinomas in B6C3F1 Mice Treated with G...
MicroRNA Profiling of Hepatocellular Carcinomas in B6C3F1 Mice Treated with G...
EPL, Inc.
Clinical Surgery Research Communications
A review of micro rn as related to the occurrence, diagnosis, and prognosis o...
A review of micro rn as related to the occurrence, diagnosis, and prognosis o...
Clinical Surgery Research Communications
Clinical Surgery Research Communications
Roles of circular rn as and their interactions with micro rnas in human disor...
Roles of circular rn as and their interactions with micro rnas in human disor...
Clinical Surgery Research Communications
Galvan et al. - COL11A1 BMC Cancer 2014
Galvan et al. - COL11A1 BMC Cancer 2014
Jose A. Galvan
Clinical Surgery Research Communications
The role of micro rn as in the occurrence and development of esophageal squam...
The role of micro rn as in the occurrence and development of esophageal squam...
Clinical Surgery Research Communications
ICC Final Paper
ICC Final Paper
Victoria Rael
2011 - Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 tr...
2011 - Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 tr...
Simon Gemble
Rozenchan_et_al-2009-International_Journal_of_Cancer
Rozenchan_et_al-2009-International_Journal_of_Cancer
Patricia Rozenchan
Poster based on Summer internship in Rutgers 2014
The expression of ITPK in normal colon and colorectal cancer cells - Poster
The expression of ITPK in normal colon and colorectal cancer cells - Poster
maldjuan
Presentation based on Summer internship in Rutgers 2014
The expression of ITPK in normal colon and colorectal cancer cells - Presenta...
The expression of ITPK in normal colon and colorectal cancer cells - Presenta...
maldjuan
Paper written after the summer of the Rutgers research experience.
The expression of ITPK in normal colon and colorectal cancer cells - Paper
The expression of ITPK in normal colon and colorectal cancer cells - Paper
maldjuan
TGR5 as a marker for advanced gatsric cancer-Fiorucci Stefano poster presented at the DDW 2016- San Diego (CA) May 21-25, 2016
Tgr5 and gastric cancer ddw2016
Tgr5 and gastric cancer ddw2016
Attività scientifica
Oncotarget
Oncotarget
Aaron Bholé
Inhibition of KPNA4 Attenuates Prostate Cancer Metastasis
Inhibition of KPNA4 Attenuates Prostate Cancer Metastasis
Xin Li
MasterThesis
MasterThesis
Elena Busso
Propolis with its active component CAPE (Caffeic Acid Phenethyl Ester) stops breast cancer cell growth. These results of CAPE are present in the naturopathic formulation of propolis, a widely available natural substance with an extended safety record, making it a naturally-occurring and readily available epigenetic agent with great potential in breast cancer and oncology in general. The ability to link the biological effects of a naturopathic remedy to the pharmacologic effects seen with an exciting class of drugs in the treatment of cancer opens the door to a host of new therapeutic opportunities for patients.
Propolis with CAPE Modulates Breast Cancer Cells
Propolis with CAPE Modulates Breast Cancer Cells
Bee Healthy Farms
1476-4598-2-38
1476-4598-2-38
Christian Schmidt
2014 molecular mechanisms involved in the cytotoxicity induced
2014 molecular mechanisms involved in the cytotoxicity induced
Ricardo Reyes Chilpa. Instituto de Química. UNAM
sclabas2005
sclabas2005
Christian Schmidt
cancerres
cancerres
Christian Schmidt
Although advanced-stage cervical cancer can benefit from current treatments, approximately 30% patients may fail after definitive treatment eventually. Therefore, exploring alternative molecular therapeutic approaches is imperatively needed for this disease. We have recently shown that activation of AMP-activated protein kinase (AMPK), a metabolic sensor, hampers cervical cancer cell growth through blocking the Wnt/β-catenin signaling activity. Here, we report that activated AMPK (p-AMPK) also inhibits cervical cancer cell growth by counteracting FOXM1 function.
Activation of AMPK inhibits cervical cancer cell growth through AKT/FOXO3a/FO...
Activation of AMPK inhibits cervical cancer cell growth through AKT/FOXO3a/FO...
Enrique Moreno Gonzalez
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kd...
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kd...
Mark Lipstein
The IRF family of proteins involves in the tumor progression. However, but the functions of IRF5 in the tumorigenesis are largely unknown. Here, IRF5 was found to be up-regulated in hepatocellular carcinoma (HCC). Interfering with IRF5 inhibited the growth and tumorigenic ability of HCC cells. When studying the molecular mechanism, it was found that TRIM35 interacted with IRF5, promoting the ubiquitination and degradation of IRF5. In the clinical specimens of HCC, TRIM35 was negatively correlated with the expression of IRF5. These observations reveal the oncogenic function of IRF5 in the progression of HCC, suggesting that IRF5 is a promising target for the therapy of HCC.
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
daranisaha
The IRF family of proteins involves in the tumor progression. However, but the functions of IRF5 in the tumorigenesis are largely unknown. Here, IRF5 was found to be up-regulated in hepatocellular carcinoma (HCC). Interfering with IRF5 inhibited the growth and tumorigenic ability of HCC cells. When studying the molecular mechanism, it was found that TRIM35 interacted with IRF5, promoting the ubiquitination and degradation of IRF5. In the clinical specimens of HCC, TRIM35 was negatively correlated with the expression of IRF5. These observations reveal the oncogenic function of IRF5 in the progression of HCC, suggesting that IRF5 is a promising target for the therapy of HCC.
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
eshaasini
Weitere ähnliche Inhalte
Was ist angesagt?
Clinical Surgery Research Communications
Roles of circular rn as and their interactions with micro rnas in human disor...
Roles of circular rn as and their interactions with micro rnas in human disor...
Clinical Surgery Research Communications
Galvan et al. - COL11A1 BMC Cancer 2014
Galvan et al. - COL11A1 BMC Cancer 2014
Jose A. Galvan
Clinical Surgery Research Communications
The role of micro rn as in the occurrence and development of esophageal squam...
The role of micro rn as in the occurrence and development of esophageal squam...
Clinical Surgery Research Communications
ICC Final Paper
ICC Final Paper
Victoria Rael
2011 - Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 tr...
2011 - Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 tr...
Simon Gemble
Rozenchan_et_al-2009-International_Journal_of_Cancer
Rozenchan_et_al-2009-International_Journal_of_Cancer
Patricia Rozenchan
Poster based on Summer internship in Rutgers 2014
The expression of ITPK in normal colon and colorectal cancer cells - Poster
The expression of ITPK in normal colon and colorectal cancer cells - Poster
maldjuan
Presentation based on Summer internship in Rutgers 2014
The expression of ITPK in normal colon and colorectal cancer cells - Presenta...
The expression of ITPK in normal colon and colorectal cancer cells - Presenta...
maldjuan
Paper written after the summer of the Rutgers research experience.
The expression of ITPK in normal colon and colorectal cancer cells - Paper
The expression of ITPK in normal colon and colorectal cancer cells - Paper
maldjuan
TGR5 as a marker for advanced gatsric cancer-Fiorucci Stefano poster presented at the DDW 2016- San Diego (CA) May 21-25, 2016
Tgr5 and gastric cancer ddw2016
Tgr5 and gastric cancer ddw2016
Attività scientifica
Oncotarget
Oncotarget
Aaron Bholé
Inhibition of KPNA4 Attenuates Prostate Cancer Metastasis
Inhibition of KPNA4 Attenuates Prostate Cancer Metastasis
Xin Li
MasterThesis
MasterThesis
Elena Busso
Propolis with its active component CAPE (Caffeic Acid Phenethyl Ester) stops breast cancer cell growth. These results of CAPE are present in the naturopathic formulation of propolis, a widely available natural substance with an extended safety record, making it a naturally-occurring and readily available epigenetic agent with great potential in breast cancer and oncology in general. The ability to link the biological effects of a naturopathic remedy to the pharmacologic effects seen with an exciting class of drugs in the treatment of cancer opens the door to a host of new therapeutic opportunities for patients.
Propolis with CAPE Modulates Breast Cancer Cells
Propolis with CAPE Modulates Breast Cancer Cells
Bee Healthy Farms
1476-4598-2-38
1476-4598-2-38
Christian Schmidt
2014 molecular mechanisms involved in the cytotoxicity induced
2014 molecular mechanisms involved in the cytotoxicity induced
Ricardo Reyes Chilpa. Instituto de Química. UNAM
sclabas2005
sclabas2005
Christian Schmidt
cancerres
cancerres
Christian Schmidt
Although advanced-stage cervical cancer can benefit from current treatments, approximately 30% patients may fail after definitive treatment eventually. Therefore, exploring alternative molecular therapeutic approaches is imperatively needed for this disease. We have recently shown that activation of AMP-activated protein kinase (AMPK), a metabolic sensor, hampers cervical cancer cell growth through blocking the Wnt/β-catenin signaling activity. Here, we report that activated AMPK (p-AMPK) also inhibits cervical cancer cell growth by counteracting FOXM1 function.
Activation of AMPK inhibits cervical cancer cell growth through AKT/FOXO3a/FO...
Activation of AMPK inhibits cervical cancer cell growth through AKT/FOXO3a/FO...
Enrique Moreno Gonzalez
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kd...
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kd...
Mark Lipstein
Was ist angesagt?
(20)
Roles of circular rn as and their interactions with micro rnas in human disor...
Roles of circular rn as and their interactions with micro rnas in human disor...
Galvan et al. - COL11A1 BMC Cancer 2014
Galvan et al. - COL11A1 BMC Cancer 2014
The role of micro rn as in the occurrence and development of esophageal squam...
The role of micro rn as in the occurrence and development of esophageal squam...
ICC Final Paper
ICC Final Paper
2011 - Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 tr...
2011 - Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 tr...
Rozenchan_et_al-2009-International_Journal_of_Cancer
Rozenchan_et_al-2009-International_Journal_of_Cancer
The expression of ITPK in normal colon and colorectal cancer cells - Poster
The expression of ITPK in normal colon and colorectal cancer cells - Poster
The expression of ITPK in normal colon and colorectal cancer cells - Presenta...
The expression of ITPK in normal colon and colorectal cancer cells - Presenta...
The expression of ITPK in normal colon and colorectal cancer cells - Paper
The expression of ITPK in normal colon and colorectal cancer cells - Paper
Tgr5 and gastric cancer ddw2016
Tgr5 and gastric cancer ddw2016
Oncotarget
Oncotarget
Inhibition of KPNA4 Attenuates Prostate Cancer Metastasis
Inhibition of KPNA4 Attenuates Prostate Cancer Metastasis
MasterThesis
MasterThesis
Propolis with CAPE Modulates Breast Cancer Cells
Propolis with CAPE Modulates Breast Cancer Cells
1476-4598-2-38
1476-4598-2-38
2014 molecular mechanisms involved in the cytotoxicity induced
2014 molecular mechanisms involved in the cytotoxicity induced
sclabas2005
sclabas2005
cancerres
cancerres
Activation of AMPK inhibits cervical cancer cell growth through AKT/FOXO3a/FO...
Activation of AMPK inhibits cervical cancer cell growth through AKT/FOXO3a/FO...
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kd...
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kd...
Ähnlich wie Poster Aacr 2010 Pettersson 2
The IRF family of proteins involves in the tumor progression. However, but the functions of IRF5 in the tumorigenesis are largely unknown. Here, IRF5 was found to be up-regulated in hepatocellular carcinoma (HCC). Interfering with IRF5 inhibited the growth and tumorigenic ability of HCC cells. When studying the molecular mechanism, it was found that TRIM35 interacted with IRF5, promoting the ubiquitination and degradation of IRF5. In the clinical specimens of HCC, TRIM35 was negatively correlated with the expression of IRF5. These observations reveal the oncogenic function of IRF5 in the progression of HCC, suggesting that IRF5 is a promising target for the therapy of HCC.
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
daranisaha
The IRF family of proteins involves in the tumor progression. However, but the functions of IRF5 in the tumorigenesis are largely unknown. Here, IRF5 was found to be up-regulated in hepatocellular carcinoma (HCC). Interfering with IRF5 inhibited the growth and tumorigenic ability of HCC cells. When studying the molecular mechanism, it was found that TRIM35 interacted with IRF5, promoting the ubiquitination and degradation of IRF5. In the clinical specimens of HCC, TRIM35 was negatively correlated with the expression of IRF5. These observations reveal the oncogenic function of IRF5 in the progression of HCC, suggesting that IRF5 is a promising target for the therapy of HCC.
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
eshaasini
The IRF family of proteins involves in the tumor progression. However, but the functions of IRF5 in the tumorigenesis are largely unknown. Here, IRF5 was found to be up-regulated in hepatocellular carcinoma (HCC). Interfering with IRF5 inhibited the growth and tumorigenic ability of HCC cells. When studying the molecular mechanism, it was found that TRIM35 interacted with IRF5, promoting the ubiquitination and degradation of IRF5. In the clinical specimens of HCC, TRIM35 was negatively correlated with the expression of IRF5. These observations reveal the oncogenic function of IRF5 in the progression of HCC, suggesting that IRF5 is a promising target for the therapy of HCC.
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
semualkaira
The IRF family of proteins involves in the tumor progression. However, but the functions of IRF5 in the tumorigenesis are largely unknown. Here, IRF5 was found to be up-regulated in hepatocellular carcinoma (HCC). Interfering with IRF5 inhibited the growth and tumorigenic ability of HCC cells. When studying the molecular mechanism, it was found that TRIM35 interacted with IRF5, promoting the ubiquitination and degradation of IRF5. In the clinical specimens of HCC, TRIM35 was negatively correlated with the expression of IRF5. These observations reveal the oncogenic function of IRF5 in the progression of HCC, suggesting that IRF5 is a promising target for the therapy of HCC.
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
semualkaira
The IRF family of proteins involves in the tumor progression. However, but the functions of IRF5 in the tumorigenesis are largely unknown. Here, IRF5 was found to be up-regulated in hepatocellular carcinoma (HCC). Interfering with IRF5 inhibited the growth and tumorigenic ability of HCC cells. When studying the molecular mechanism, it was found that TRIM35 interacted with IRF5, promoting the ubiquitination and degradation of IRF5. In the clinical specimens of HCC, TRIM35 was negatively correlated with the expression of IRF5. These observations reveal the oncogenic function of IRF5 in the progression of HCC, suggesting that IRF5 is a promising target for the therapy of HCC.
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
semualkaira
The IRF family of proteins involves in the tumor progression. However, but the functions of IRF5 in the tumorigenesis are largely unknown. Here, IRF5 was found to be up-regulated in hepatocellular carcinoma (HCC). Interfering with IRF5 inhibited the growth and tumorigenic ability of HCC cells.
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
JohnJulie1
The IRF family of proteins involves in the tumor progression. However, but the functions of IRF5 in the tumorigenesis are largely unknown. Here, IRF5 was found to be up-regulated in hepatocellular carcinoma (HCC). Interfering with IRF5 inhibited the growth and tumorigenic ability of HCC cells. When studying the molecular mechanism, it was found that TRIM35 interacted with IRF5, promoting the ubiquitination and degradation of IRF5. In the clinical specimens of HCC, TRIM35 was negatively correlated with the expression of IRF5. These observations reveal the oncogenic function of IRF5 in the progression of HCC, suggesting that IRF5 is a promising target for the therapy of HCC.
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
NainaAnon
Lipopolysaccharide (LPS) stimulated TLR-4 mediated signalling has been shown to accentuate the metastasis in a variety of cancers. In a murine mammary cancer model, LPS has been found to trigger lung metastasis. However there are very few studies which report the pro-tumor properties of LPS in lung cancer. In this study we investigated the effect of LPS on Fibronectin induced metastatic progression in human lung cancer cells. Lower concentrations of LPS exhibited a pro-proliferative effect on A549 cells. Using such concentrations of LPS to stimulate A549 cells, expression of Fibronectin mRNA increased in comparison to control. 0.5 -µg of LPS treatment led to the two fold increase in mRNA expression of Fibronectin. Moreover, LPS stimulation augmented the migratory ability of A549 cells as assessed by wound healing assay. This increase in migration of A549 cells was in agreement with the expression pattern of Fibronectin induced by LPS stimulation. Taken together this study presents a preliminary account of the role of LPS in inducing the expression of Fibronectin and metastatic progression in lung carcinoma. Asif Amin | Taseem A. Mokhdomi | Asrar H. Wafai | Raies A. Qadri"Lipopolysaccharide promotes the metastatic Potential of Lung Carcinoma Cells by Upregulating the Expression of Fibronectin" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-2 | Issue-1 , December 2017, URL: http://www.ijtsrd.com/papers/ijtsrd7164.pdf http://www.ijtsrd.com/biological-science/cell-biology/7164/lipopolysaccharide-promotes-the-metastatic-potential-of-lung-carcinoma-cells-by-upregulating-the-expression-of-fibronectin/asif-amin
Lipopolysaccharide promotes the metastatic Potential of Lung Carcinoma Cells ...
Lipopolysaccharide promotes the metastatic Potential of Lung Carcinoma Cells ...
ijtsrd
International peer-reviewed academic journals call for papers, http://www.iiste.org/Journals
Molecular localization of epstein barr virus and rb tumor suppressor gene exp...
Molecular localization of epstein barr virus and rb tumor suppressor gene exp...
Alexander Decker
ringel2001
ringel2001
Christian Schmidt
Breast cancer is the most common female malignancy and is responsible for about 14% of cancer-related deaths in women [1]. Triple-negative breast cancer (TNBC), characterized by the absence of expression of Estrogen Receptor (ER), Progesterone Receptor (PR), and human epidermal growth factor receptor 2 (HER2), is the most aggressive and deadly subtype of breast cancer
Triple_Negative_Breast_Cancer_Is_it_Poss.pdf
Triple_Negative_Breast_Cancer_Is_it_Poss.pdf
semualkaira
Moringa kills-human-pancreatic-cancer-cells
Moringa kills-human-pancreatic-cancer-cells
Drumstick Moringa
Carcinoma associated fibroblasts (CAFs) are known responsible for immune evasion and growth of cancer and the crosstalk between CAFs and the immune system is still unidentified.
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
daranisaha
Carcinoma associated fibroblasts (CAFs) are known responsible for immune evasion and growth of cancer and the crosstalk between CAFs and the immune system is still unidentified.
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
AnonIshanvi
Carcinoma associated fibroblasts (CAFs) are known responsible for immune evasion and growth of cancer and the crosstalk between CAFs and the immune system is still unidentified.
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
JohnJulie1
Carcinoma associated fibroblasts (CAFs) are known responsible for immune evasion and growth of Carcinoma associated fibroblasts (CAFs) are known responsible for immune evasion and growth of cancer and the crosstalk between CAFs and the immune system is still unidentified.cancer and the crosstalk between CAFs and the immune system is still unidentified.
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
semualkaira
Carcinoma associated fibroblasts (CAFs) are known responsible for immune evasion and growth of cancer and the crosstalk between CAFs and the immune system is still unidentified.
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
semualkaira
Carcinoma associated fibroblasts (CAFs) are known responsible for immune evasion and growth of cancer and the crosstalk between CAFs and the immune system is still unidentified.
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
semualkaira
Carcinoma associated fibroblasts (CAFs) are known responsible for immune evasion and growth of cancer and the crosstalk between CAFs and the immune system is still unidentified
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
EditorSara
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages Influences Immune Response in Cancer
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
NainaAnon
Ähnlich wie Poster Aacr 2010 Pettersson 2
(20)
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
Lipopolysaccharide promotes the metastatic Potential of Lung Carcinoma Cells ...
Lipopolysaccharide promotes the metastatic Potential of Lung Carcinoma Cells ...
Molecular localization of epstein barr virus and rb tumor suppressor gene exp...
Molecular localization of epstein barr virus and rb tumor suppressor gene exp...
ringel2001
ringel2001
Triple_Negative_Breast_Cancer_Is_it_Poss.pdf
Triple_Negative_Breast_Cancer_Is_it_Poss.pdf
Moringa kills-human-pancreatic-cancer-cells
Moringa kills-human-pancreatic-cancer-cells
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
Functional Disparity of Carcinoma Associated Fibroblasts in Different Stages ...
Poster Aacr 2010 Pettersson 2
1.
Jetzt herunterladen